Nasdaq:US$36.56 (-0.93) | HKEX:HK$57.55 (-1.15) | AIM:£5.31 (-0.07)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 其他業務 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture